髓过氧化物酶特异性抗中性粒细胞胞质抗体相关性血管炎
本文为系列综述,阐述髓过氧化物酶(MPO)特异性抗中性粒细胞胞质抗体(ANCA)相关性血管炎的发病机制、诊断与治疗现状。该病主要累及小血管,肾脏和肺最常受累,临床试验已改善治疗策略,但复发频率、当前治疗毒性及长期疾病负担方面仍存在显著未满足需求。
要点
- MPO-ANCA相关性血管炎主要累及小血管,与蛋白酶3-ANCA相关性血管炎不同,一般无肉芽肿性炎症。
- 肾脏和肺是最常受累器官,发病核心为对中性粒细胞酶MPO的免疫耐受丧失。
- 中性粒细胞既是自身免疫的靶点也是效应细胞,MPO-ANCA驱动中性粒细胞活化导致组织器官损伤。
核心结论
- MPO-ANCA相关性血管炎是以少免疫沉积性系统性坏死性血管炎为特征的两大ANCA相关性血管炎类型之一。
- 临床试验已改善MPO-ANCA相关性血管炎的治疗策略,但在复发频率、当前治疗毒性及长期疾病负担方面仍存在显著未满足需求。
研究设计与样本
- 本文为系列综述,总结MPO-ANCA相关性血管炎在发病机制、诊断和治疗方面的研究现状。
主要发现
- MPO-ANCA相关性血管炎主要累及小血管,与蛋白酶3-ANCA相关性血管炎不同,一般不与肉芽肿性炎症相关。
- 肾脏和肺是最常受累的器官。
- 发病机制特征为对中性粒细胞酶MPO的免疫耐受丧失,导致慢性免疫病理反应,中性粒细胞成为自身免疫的靶点和效应细胞。
- MPO-ANCA驱动中性粒细胞活化,进而导致组织和器官损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (MPO-ANCA-associated vasculitis) is one of two major ANCA-associated vasculitis variants characterised by systemic necrotising vasculitis with few or no immune deposits. MPO-ANCA-associated vasculitis predominantly affects small blood vessels and, in contrast to its counterpart proteinase 3-ANCA-associated vasculitis, is generally not associated with granulomatous inflammation. The kidneys and lungs are the most commonly affected organs. The pathogenesis of MPO-ANCA-associated vasculitis is characterised by loss of tolerance to the neutrophil enzyme MPO. This loss of tolerance leads to a chronic immunopathological response where neutrophils become both the target and effector of autoimmunity. MPO-ANCA drives neutrophil activation, leading in turn to tissue and organ damage. Clinical trials have improved the therapeutic approach to MPO-ANCA-associated vasculitis. However, there remains substantial unmet need regarding relapse frequency, toxicity of current treatment, and long-term morbidity. In this Series paper, we present the current state of research regarding pathogenesis, diagnosis, and treatment of MPO-ANCA-associated vasculitis.
引用
- Arnold S, Kitching AR, Witko-Sarsat V, et al. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol. 2024. PMID: 38574743. doi:10.1016/S2665-9913(24)00025-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。